Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance.
- NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_assertion description "[The authors evaluated 17 SNPs of the CDA,dCK, DCTD, RRM1, hCNT1-3, and hENT1 genes in 149 patients with locally advanced pancreatic cancer who underwent gemcitabine-based chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance.
- NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_assertion evidence source_evidence_literature NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance.
- NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_assertion SIO_000772 20665488 NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance.
- NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_assertion wasDerivedFrom befree-20140225 NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance.
- NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_assertion wasGeneratedBy ECO_0000203 NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP695210.RAQW2_f7SFwt2K82-IJSFpz3B0lIKvbFXZLJe5FVmLwL4130_provenance.